Nucala 100 MG/ML auto-injectorml
Ended Awarded Last action
- Contract number
- SPE2DR26FJUZ1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,182
Award facts
- Contract value 100% obligated
- $23,181.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,181.96 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Nucala 100 mg/ml auto-injector. The delivery order, issued on January 29, 2026, with an ultimate completion date of January 30, 2026, contains no set-aside designation, indicating the award was made through unrestricted federal procurement. DMS Pharmaceutical Group is performing at its headquarters location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, valued at $499,999,999 through December 31, 2036. The underlying IDC, awarded November 13, 2025, authorizes DLA to issue delivery orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. Nucala is a biologic immunosuppressant agent that represents one of many specialty pharmaceuticals within DMS Pharmaceutical Group's comprehensive product portfolio supplied to federal agencies.
Quick answers
Who was awarded contract SPE2DR26FJUZ1?
SPE2DR26FJUZ1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FJUZ1 worth?
The government has obligated $23,182 on SPE2DR26FJUZ1.
Is contract SPE2DR26FJUZ1 an order under another contract?
Yes. SPE2DR26FJUZ1 is a delivery order under SPE2DR25D9329, an indefinite delivery contract.
Was contract SPE2DR26FJUZ1 competed?
The extent of competition for SPE2DR26FJUZ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award